Table 3.
Clinical Events.
| All-Cause Death or Heart Failure | MUGA cohort (n=1,028) |
Echo cohort (n=1,032) |
p-value | |
|---|---|---|---|---|
| Duration of follow up (days) | 2534 (1487, 3288) | 2401 (1529, 3004) | 0.0013 | |
| Total events* | 118 (11.5%) | 94 (9.1%) | 0.077 | |
| Number of events | 0-12 months | 8 (0.8%) | 12 (1.2%) | 0.373 |
| 13-24 months | 22 (2.1%) | 19 (1.8%) | 0.627 | |
| 24+ months | 88 (8.6%) | 63 (6.1%) | 0.033 | |
| Cardiovascular Death or Heart Failure | MUGA cohort (n=1,028) |
Echo cohort (n=1,032) |
p-value | |
| Duration of follow up (days) | 2534 (1487, 3288) | 2401 (1528, 3004) | 0.0012 | |
| Total events | 16 (1.6%) | 16 (1.6%) | 0.991 | |
| Number of events | 0-12 months | 4 (0.4%) | 6 (0.6%) | 0.753 |
| 13-24 months | 5 (0.5%) | 5 (0.5%) | 1.00 | |
| 24+ months | 7 (0.7%) | 5 (0.5%) | 0.579 | |
| New Heart Failure | MUGA cohort (n=1,028) |
Echo cohort (n=1,032) |
p-value | |
| Duration of follow up (days) | 2695 (1724, 3372) | 2510 (1710, 3123) | <0.001 | |
| Total events | 15 (1.5%) | 13 (1.3%) | 0.696 | |
| Number of events | 0-12 months | 3 (0.3%) | 5 (0.5%) | 0.726 |
| 13-24 months | 5 (0.5%) | 3 (0.3%) | 0.506 | |
| 24+ months | 7 (0.7%) | 5 (0.5%) | 0.579 | |
*Only first event was considered.
All results are expressed as median (25th, 75th percentile) or frequency (percentage). MUGA, multi-gated acquisition.